The Drug Utilization Review (DUR) Board serves in an advisory capacity to the Department of Health Care Policy & Financing and makes recommendations regarding drug utilization, educational interventions, and application of standards. The DUR Board also provides recommendations to the Department regarding prior authorization criteria for a wide range of drug classes and medications.
Physicians and pharmacists are being recruited on a continuous basis to fill positions on the Colorado DUR Board. If you are interested in learning more about these professional opportunities, send an inquiry to Jeff Taylor (jeffrey.taylor@state.co.us) or Julia Rawlings (julia.rawlings@state.co.us). If there are no Board openings at the time you apply, the Department will keep your information on file and may contact you in the future regarding your interest in DUR Board openings as they arise.
Newsletters
2024 Meeting Schedule and Handouts
DUR Board meetings are held in a virtual format. Zoom log in information for public attendees will be posted on this page a few days prior to each meeting.
The Department requests that DUR Board meeting speakers and guests keep their video cameras and microphones turned off during the meeting. Registered speakers will be invited to provide testimony at the appropriate times on the meeting agenda.
Open session time is 1:00 p.m. - 5:00 p.m.
The Colorado DUR Board meets quarterly in February, May, August, and November.
There is currently an open seat for a DUR Board physician member. If you are interested in applying for this open position, send an inquiry along with your CV to Jeff Taylor (jeffrey.taylor@state.co.us) or Julia Rawlings (julia.rawlings@state.co.us)
November 12, 2024, 1:00 pm - 5:00 pm
To Be Announced
August 13, 2024, 1:00 pm - 5:00 pm
To Be Announced
May 7, 2024, 1:00 pm - 5:00 pm
Health First Colorado DUR Board - May 2024 Meeting
May 7, 2024 1:00 PM Mountain Time (US and Canada)
Join Zoom Meeting https://ucdenver.zoom.us/j/99442774963
Meeting ID: 994 4277 4963
---
One tap mobile
+17193594580,,99442774963# US
+13462487799,,99442774963# US (Houston)
---
Dial by your location
• +1 719 359 4580 US
• +1 346 248 7799 US (Houston)
• +1 669 444 9171 US
• +1 669 900 6833 US (San Jose)
• +1 253 205 0468 US
• +1 253 215 8782 US (Tacoma)
• +1 564 217 2000 US
• +1 646 876 9923 US (New York)
• +1 646 931 3860 US
• +1 689 278 1000 US
• +1 301 715 8592 US (Washington DC)
• +1 305 224 1968 US
• +1 309 205 3325 US
• +1 312 626 6799 US (Chicago)
• +1 360 209 5623 US
• +1 386 347 5053 US
• +1 507 473 4847 US
February 13, 2024, 1:00 pm - 5:00 pm
2023 Meeting Schedule and Handouts
November 14, 2023, 1:00 pm - 5:00 pm
August 8, 2023, 1:00 pm - 5:00 pm
May 9, 2023, 1:00 pm - 5:00 pm
February 7, 2023, 1:00 pm - 5:00 pm
Our Members
The Board consists of nine members appointed by the Executive Director, four physicians, four pharmacists licensed and actively practicing in Colorado, and one non-voting pharmaceutical industry representative.
DUR Policy and Procedure Manual
Contact Us/Join Us
Program Administrators
Denver, CO 80203
Presenting Testimony
Auxiliary aids and services for individuals with disabilities and language services for individuals whose first language is not English may be provided upon request. Please notify Jeffrey Taylor at jeffrey.taylor@state.co.us or the Civil Rights Officer at hcpf504ada@state.co.us at least one week prior to the meeting to make arrangements.